论文部分内容阅读
单独定价药品在新一轮药品招标中又摊上大事了。4月20日,有媒体曝光了常用药克拉霉素改变剂型,由普通胶囊改成软胶囊,就摇身一变成为独家品种、享受单独定价后身价比普通胶囊高出22倍的消息。随后马上就有业内人士称,部分原研药明明专利已到期,却仍能享受单独定价,明明价格比同类药品高出20倍,也能轻松中标,相当有失公平、公正。为此,广东一药企还将国家发改委告上了法庭。(4月21日《羊城晚报》)
Price-fixing drugs in the new round of bidding again in the big event. April 20, the media exposure of commonly used drugs clarithromycin change dosage form, from ordinary capsules into soft capsules, it transformed into an exclusive variety, enjoying a single price after 22 times higher than ordinary capsules news. Then immediately there are people in the industry said that some of the original drug clearly patent has expired, but still be able to enjoy a separate pricing, the price obviously higher than similar drugs 20 times, can easily bid, quite unfair and fair. To this end, a pharmaceutical company in Guangdong will also report to the National Development and Reform Commission. (April 21, “Yangcheng Evening News”)